You are here:

Way Ahead Volume 17 Part 4 (October 2013)

Cochrane review of the effectiveness of disease modifying therapies used in MS

Martin Duddy, Consultant Neurologist, Royal Victoria Infirmary, Newcastle-upon-Tyne

In June 2013, the Cochrane Collaboration published a review of the immunomodulators and immunosuppressants licensed at that time for use in MS. This article looks at how the review was carried out, and places the findings of the report within the context of the changing landscape in MS.

Rehabilitation in people with multiple sclerosis 

Diane Playford, Senior Lecturer/Consultant Neurologist, UCL Institute of Neurology, London

This article explores the value of rehabilitation in people with MS even in the early stages of the disease course. Looks at assessment, goal setting, treatment and evaluation.

Measuring and improving the experiences of care for people with MS 

Geraldine Mynors, Independent Consultant, Mynors Suppiah.

Following on from her attendance at the NICE annual conference, Geraldine reflects on the new NICE patient experience guideline and how the MS Trust GEMSS patient survey can be used as a tool to help implement it in local MS services.

Exercise for life: evidence based, specialist provision in the community 

Ruth Mahood, Neurophysiotherapist, NHS Tayside, Dundee

There is evidence that regular exercise improves balance, mobility and fitness in people with MS. This article explores the development and benefits of a community-based exercise class for people with MS in Shetland.

Print this page